Microba
Business Services · Australia · 51-200 Employees
View Company Info for Free
Overview
Headquarters
324 Queen St, Brisbane City, Queensland,...Phone Number
+611300974621Website
www.microba.comRevenue
$10.7 MillionStock Symbol
MAPIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
2
1
1
1
1
About Microba
Microba Life Sciences is a pioneering precision microbiome company focused on developing health solutions through advanced understanding of the microbiome. They specialize in next-generation gastrointestinal diagnostics and therapeutic discovery aimed at addressing major chronic diseases. Their comprehensive platform technologies, including analysis, discovery, and therapeutic platforms, facilitate groundbreaking research and innovation in microbiome science. Targeting specialists, clinicians, and patients, Microba partners with leading organizations globally to drive discoveries that improve human health.Explore more
Microba Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Microba your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Microba is spiking on competitors!
Earning: See what the market has to say on Microba recently announced quarterly report
Microba, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Microba
Click to see if Microba had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Microba has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Microba launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Microba has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Microba
Compare insights from companies similar to Microba, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Microba is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Microba is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Microba.
Microba financials insights
Gather financial insights about Microba, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Share Placement
$17.8M
Microba Tech Stack
A closer look at the technologies used by Microba
See more technologies
Most Recent Scoops
Partnership
Microba has entered into a formal partnering process with Boston-based advisor Kai Bora to seek a transaction for its live biotherapeutic assets, with the formal campaign officially commencing in July following initial meetings at the BIO conference in San Diego, with a successful transaction expected to have a material impact on the valuation of Microba.
Partnership, Business Finance, Finance
Project
Microba has signed 43 enterprise healthcare clinic accounts in Australia since commencing targeted key account outreach in November 2025, with those accounts generating 606 tests sold, up 87% quarter on quarter.
CRM, Sales, Account Management
Earnings
Microba has reported that its continuing products core tests, key partners, and in vivo supplements grew 53% year on year in FY26, while strategically discontinued products declined 72% year on year as planned, positioning the business for focused, scalable growth toward cash flow break-even.
Earnings, Product Development, Finance
Project
Microba has announced plans to launch GI Navigator, a new microbiome and gut testing product designed to address patients with unresolved gastrointestinal disorders and enable rapid clinical interpretation by any healthcare professional, targeting a September 2026 release at premium pricing to expand the serviceable addressable market across medical doctors.
Product Development, Doctors / Physicians, Medical Research, Pricing
Project
CRM, Business Development, Account Management
Microba News & Media
Microba Announces Landmark GI Study Results From Over 4,600 Patients
BRISBANE, Australia--(BUSINESS WIRE)-- #microbiome--Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”), a precision microbiome company, today announces preliminary results from the analysis of over 4,600 MetaXplore™ GI Plus test results, a comprehensive test for the assessment and management of lower gastrointestinal disorders, spanning symptoms including chronic pain, bloating, constipation, or diarrhea. This study demonstrates that MetaXplore can support clinicians to identiMicroba Delivers Landmark IBD Results & Signs Major Gastro Partner
BRISBANE, Australia--(BUSINESS WIRE)-- #microbiome--Microba Life Sciences Limited (ASX: MAP) (“Microba”) a precision microbiome company, today announces two significant developments: the release of new clinical utility results for its MetaPanel™ gastrointestinal pathogen test, and the signing of a strategic clinical partnership with the Colonoscopy Clinic, and its wholly owned partner, Integrated Gut Health, one of Australia’s leading gastroenterology services. Transforming IBD Care: MetaPanel™Mercer Investments Acquires Stake in Microba Life Sciences | Markets Insider
Microba Life Sciences Limited (AU:MAP) has released an update.Don't Miss Our New Year's Offers:Discover the latest stocks recommended by top Wal...Clinical Microbiomics A/S Announces New Deal with Microba Life Sciences Ltd's and Prepares to Launch New Company Brand in November 2024
COPENHAGEN, Denmark, Oct. 15, 2024 /PRNewswire/ -- Clinical Microbiomics A/S ("CMC"), a leading innovator in multi-omics, bioinformatics and systems biology for the microbiome field, based in Copenhagen, Denmark, announces that the company has entered into a definitive agreement whereby...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Microba
Sign Up For FreeTo access detailed company insights
Microba Life Sciences is a pioneering precision microbiome company focused on developing health solutions through advanced understanding of the microbiome. They specialize in next-generation gastrointestinal diagnostics and therapeutic discovery aimed at addressing major chronic diseases. Their comprehensive platform technologies, including analysi... Read More
